Incannex Healthcare
🇦🇺Australia
- Country
- 🇦🇺Australia
- Ownership
- -
- Employees
- 10
- Market Cap
- $34.7M
- Introduction
Incannex Healthcare, Inc. is a biotech company, which engages in developing cannabinoid and psychedelic compound medicines. It focuses on the research and development for medicinal cannabis pharmaceutical products and psychedelic medicine therapies for treatment of a range of indications. The company was founded on July 5, 2023 and is headquartered in Norwest, Australia.
Incannex Eliminates 347 Million Share Dilution Ahead of Pivotal Sleep Apnea Drug Trial Results
Incannex Healthcare has entered a binding agreement to cancel 172 million Series A Warrants for $12.2 million, eliminating up to 347.2 million shares from potential dilution when combined with earlier cancellations.
© Copyright 2025. All Rights Reserved by MedPath